Source: Circulation  |  Posted 8 years ago

Acetylcysteine reduces composite cardiovascular end points in patients undergoing haemodialysis, say German researchers.

End-stage renal failure results in increased oxidative stress and reveal elevated cardiovascular mortality. Researchers from the Berlin's Freie Universitat evaluated the thiol-containing anti-oxidant, acetylcysteine, to determine the possibility of preventing these increased cardiovascular events

Seventy six males and 58 females, mean ages 62